Citation Relationships



Schapira AH, Olanow CW (2003) Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease. Ann Neurol 53 Suppl 3:S149-57; discussion S157-9 [PubMed]

References and models cited by this paper

References and models that cite this paper

Muddapu VR, Mandali A, Chakravarthy VS, Ramaswamy S (2019) A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity. Front Neural Circuits 13:11 [Journal] [PubMed]

   Excitotoxic loss of dopaminergic cells in PD (Muddapu et al 2019) [Model]

(1 refs)